Clinical Trials Logo

Secondary Hyperoxaluria clinical trials

View clinical trials related to Secondary Hyperoxaluria.

Filter by:
  • None
  • Page 1

NCT ID: NCT03346369 Recruiting - Nephrolithiasis Clinical Trials

Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis

LaCa
Start date: August 18, 2017
Phase: Phase 3
Study type: Interventional

This study investigates the efficacy and the safety of Lanthanum Carbonate for the reduction of urinary oxalate excretion in patients with secondary hyperoxaluria and nephrolithiasis.

NCT ID: NCT03095885 Completed - Nephrolithiasis Clinical Trials

A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria

Start date: November 2016
Phase: N/A
Study type: Interventional

Identify individuals with greater absorption of oxalate based on increase in urinary oxalate excretion in response to a controlled oxalate-rich test meal.

NCT ID: NCT02547805 Completed - Nephrolithiasis Clinical Trials

Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days

Start date: September 2015
Phase: Phase 2
Study type: Interventional

Evaluate the safety, tolerability, and efficacy of 28 days of treatment with ALLN-177 for reducing urinary oxalate excretion in patients with secondary hyperoxaluria and kidney stones.

NCT ID: NCT02503345 Completed - Nephrolithiasis Clinical Trials

Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones

Start date: July 2015
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and efficacy of different doses of ALLN 177 for reducing urinary oxalate excretion in patients with secondary hyperoxaluria and recurrent kidney stones.